The DOI matches its Crossref record.
Over‐expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology
Open accessAbstract
Background and Aims: Glutamine synthetase (GS) is a useful marker in tumour liver pathology, including hepatocellular adenomas and nodules in cirrhosis. We investigated the use of GS as a marker in various clinical situations, in which FNH diagnosis had been firmly established to determine its contribution to diagnosis. Methods: Seventy‐nine cases of resected FNH, all on normal (or occasionally steatotic) livers, were retrieved from our collection. The control group was composed of hepatocellular adenomas and well‐differentiated hepatocellular carcinoma. The following stains: H&E, Masson's trichrome, Gordon‐Sweet, PAS, perls and immunostains: CK7 and 19, and GS were carried out. FNH was diagnosed based on traditional pathological techniques. In case of uncertainty, particularly with hepatocellular adenoma, additional immunostainings including liver fatty acid‐binding protein, serum amyloid A and β‐catenin were performed. Results: Glutamine synthetase immunostaining was similar in all FNH cases. Positive GS staining of hepatocytic cytoplasms formed large areas, anastomosed in a ‘map‐like’ pattern, often surrounding hepatic veins, whereas GS was not expressed in hepatocytes close to fibrotic bands containing arteries and ductules. In comparison, hepatocellular adenoma staining was completely different, even in cases of fibrotic bands due to tumour remodelling related to necrosis or haemorrhage. In hepatocellular adenomas or well‐differentiated hepatocellular carcinoma presenting β‐catenin mutation, GS was positive but with a completely different pattern that appeared diffuse and not ‘map‐like’. Conclusion: Regardless of the FNH size or steatotic content, GS produced a similar and characteristic pattern and consequently represents a good marker for easily identifying resected FNH from other hepatocellular nodules.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
EASL Clinical Practice Guidelines on the management of benign liver tumours
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.001 · Cited by 534
The biology of Hepatocellular carcinoma: implications for genomic and immune therapies
Khemlina, G., Ikeda, S., & Kurzrock, R. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0712-x · Cited by 464
Hepatocellular adenoma management and phenotypic classification: The Bordeaux experience†
Bioulac‐Sage, P., Laumonier, H., Couchy, G., Le Bail, B., Sa Cunha, A., Rullier, A., Laurent, C., Blanc, J., Cubel, G., Trillaud, H., et al. (2009) · Hepatology · doi:10.1002/hep.22995 · Cited by 439
Self-citationHepatocellular Benign Tumors—From Molecular Classification to Personalized Clinical Care
Nault, J., Bioulac–Sage, P., & Zucman–Rossi, J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.032 · Cited by 299
Self-citationHuang, W.-J., Tsai, J.-H., & Jeng, Y.-M. (2017) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.09.013 · Cited by 38
Metadata
- Authors
- Bioulac‐Sage, P., Laumonier, H., Rullier, A., Cubel, G., Laurent, C., Zucman‐Rossi, J., & Balabaud, C.
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2009-02-04
- Volume
- 29
- Issue
- 3
- Pages
- 459-465
- ISSN
- 0106-9543 (ISSN-L)
- 1478-3223
- 1478-3231
- OpenAlex
- W1967167345
- Cited by
- 158
- References
- 0
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Over‐expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. https://app.cochat.ai/papers/10.1111/j.1478-3231.2008.01849.x
- The paper
- Bioulac‐Sage, P., Laumonier, H., Rullier, A., Cubel, G., Laurent, C., Zucman‐Rossi, J., & Balabaud, C. (2009). Over‐expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver International. https://doi.org/10.1111/j.1478-3231.2008.01849.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.